Amgen, Inc. acquires KAI Pharmaceuticals, Inc.

On July 5, 2012, Amgen, Inc. acquired KAI Pharmaceuticals, Inc., a life science company in California, United States.

Deal at a glance

AnnouncedJuly 5, 2012 TypeAdd-on Acquistion TargetKAI Pharmaceuticals, Inc. Buyer Amgen, Inc. SectorLife Science LocationCalifornia, United States ValueNot disclosed

Target company

KAI Pharmaceuticals, Inc.

California, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Amgen, Inc.

Company · 28 deals on record

18th transaction in life science
15th transaction in United States

28deals, all time

24in this sector

2021latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired KAI Pharmaceuticals, Inc.?Amgen, Inc. acquired KAI Pharmaceuticals, Inc. on July 5, 2012.

What type of deal was it?It was a add-on acquistion in the life science sector in 2012.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).